| Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature GI Rice, PR Kasher, GMA Forte, NM Mannion, SM Greenwood, ... Nature genetics 44 (11), 1243-1248, 2012 | 1032 | 2012 |
| JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies GAM Sanchez, A Reinhardt, S Ramsey, H Wittkowski, PJ Hashkes, ... The Journal of clinical investigation 128 (7), 3041-3052, 2018 | 564 | 2018 |
| Classification criteria for autoinflammatory recurrent fevers M Gattorno, M Hofer, S Federici, F Vanoni, F Bovis, I Aksentijevich, ... Annals of the rheumatic diseases 78 (8), 1025-1032, 2019 | 557 | 2019 |
| Canakinumab for the treatment of autoinflammatory recurrent fever syndromes F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ... New England Journal of Medicine 378 (20), 1908-1919, 2018 | 542 | 2018 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 449 | 2021 |
| A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis RB Jones, AJ Ferraro, AN Chaudhry, P Brogan, AD Salama, KGC Smith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 446 | 2009 |
| Management of Kawasaki disease D Eleftheriou, M Levin, D Shingadia, R Tulloh, NJ Klein, PA Brogan Archives of disease in childhood 99 (1), 74-83, 2014 | 415 | 2014 |
| European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative S Ozen, SD Marks, P Brogan, N Groot, N de Graeff, T Avcin, ... Rheumatology 58 (9), 1607-1616, 2019 | 395 | 2019 |
| Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease RC Dale, F Brilot, LV Duffy, M Twilt, AT Waldman, S Narula, E Muscal, ... Neurology 83 (2), 142-150, 2014 | 388 | 2014 |
| The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry HJ Lachmann, R Papa, K Gerhold, L Obici, I Touitou, L Cantarini, ... Annals of the rheumatic diseases 73 (12), 2160-2167, 2014 | 348 | 2014 |
| Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production A Brehm, Y Liu, A Sheikh, B Marrero, E Omoyinmi, Q Zhou, ... The Journal of clinical investigation 125 (11), 4196-4211, 2015 | 347 | 2015 |
| Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research PA Brogan, A Bose, D Burgner, D Shingadia, R Tulloh, C Michie, N Klein, ... Archives of disease in childhood 86 (4), 286-290, 2002 | 341 | 2002 |
| Recommendations for the management of autoinflammatory diseases NM Ter Haar, M Oswald, J Jeyaratnam, J Anton, KS Barron, PA Brogan, ... Annals of the rheumatic diseases 74 (9), 1636-1644, 2015 | 339 | 2015 |
| EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I … N Ruperto, S Ozen, A Pistorio, P Dolezalova, P Brogan, DA Cabral, ... Annals of the rheumatic diseases 69 (5), 790-797, 2010 | 321 | 2010 |
| Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis EM Miloslavsky, RP Naden, JWJ Bijlsma, PA Brogan, ES Brown, ... Annals of the rheumatic diseases 76 (3), 543-546, 2017 | 261 | 2017 |
| Juvenile polyarteritis: results of a multicenter survey of 110 children S Ozen, J Anton, N Arisoy, A Bakkaloglu, N Besbas, P Brogan, ... The Journal of pediatrics 145 (4), 517-522, 2004 | 261 | 2004 |
| Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial RB Jones, TF Hiemstra, J Ballarin, DE Blockmans, P Brogan, A Bruchfeld, ... Annals of the rheumatic diseases 78 (3), 399-405, 2019 | 260 | 2019 |
| EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis N Basu, R Watts, I Bajema, B Baslund, T Bley, M Boers, P Brogan, ... Annals of the rheumatic diseases 69 (10), 1744-1750, 2010 | 256 | 2010 |
| European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative N Groot, N De Graeff, T Avcin, B Bader-Meunier, P Brogan, P Dolezalova, ... Annals of the rheumatic diseases 76 (11), 1788-1796, 2017 | 245 | 2017 |
| European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease–the SHARE initiative N de Graeff, N Groot, S Ozen, D Eleftheriou, T Avcin, B Bader-Meunier, ... Rheumatology 58 (4), 672-682, 2019 | 234 | 2019 |
